FOI release

Request for Clinical Overview – FOI Reference FOI2026/00152

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2026/00324

Received 24 March 2026

Published 8 May 2026

Request

Dear MHRA Team, With reference to our ongoing Freedom of Information (FOI) request (Our Ref: FOI2026/00152), we kindly request the agency to provide the Clinical Overview for the following Marketing Authorisation. Product Name: Doxazosin Tablets 8 mg MAH: Ennogen IP Ltd, UK MA No.: PL 55612/0034 Requested Document: Clinical Overview For the agency’s reference, the FOI response previously received from MHRA has been attached. We would appreciate your assistance in providing the requested document at your earliest convenience. Thank you for your support. Regards, Yogesh Patani

Response

See attached

Documents

• FOI2026_00324 (redacted).pdf (642.1 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.